Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.00
Bid: 98.80
Ask: 99.80
Change: 1.00 (1.02%)
Spread: 1.00 (1.012%)
Open: 99.60
High: 99.80
Low: 99.00
Prev. Close: 98.00
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Oct 2023 10:27

RNS Number : 0807Q
De La Rue PLC
13 October 2023
 

De La Rue plc

(the "Company")

 

Director/PDMR Shareholding

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

13 October 2023

De La Rue plc announces that on 12 October 2023 it granted awards under the De La Rue Performance Share Plan 2020 (the "PSP") and the De La Rue Investor Returns Plan (the "IRP") to Clive Vacher and Ruth Euling, each of whom is an Executive Director and a Person Discharging Managerial Responsibilities ("PDMR") of the Company. The granting of the awards creates a change in the interests of each of them in the ordinary shares of 44152/175p of the Company ("Shares"). The awards were granted under the rules of the PSP and IRP as follows:

Name of Director/PDMR

Role

Number of Shares subject to the PSP Option

(40% of the award)

Number of Shares subject to the IRP Option

(60% of the award)

Clive Vacher

CEO

309,602

640,878

Ruth Euling

MD, Currency

102,454

212,079

 

The Options were granted on 12 October 2023 (the "Award Date"). The number of Shares contained in each Option was calculated by reference to a price of 62 pence, being the average of the closing middle market quotations for the Company's Shares for the five consecutive dealing days including and ending on 11 October 2023. 

The awards are a blended mix of PSP and IRP Options offering higher leverage and potential returns to participants for associated share price growth.

The PSP Options are granted such that vesting is subject to two equally-weighted performance conditions, which will be assessed independently, as outlined below:

Performance metric

Proportion

Threshold

Maximum

Outcome

25% vesting

100% vesting

Adjusted EPS (Average performance over 3 years)

50%

3 pence

5 pence

Free Cash Flow (3 year average)

50%

£10million

£15 million

 

Performance below Threshold will result in zero vesting. Performance between the Threshold and Maximum levels will result in a pro-rata increase in the number of Shares vesting, on a straight-line basis. Performance beyond the Maximum level will not result in any additional vesting.

The IRP Options are granted subject to the following performance condition:

Relative Total Shareholder Return Underpin

Outperformance of the FTSE 250 (ex Investment Trusts) over the three years from date of grant.

Calculated based on a net return index with 30 day averaging at the start and end of the performance period.

Equivalent to 60% of award on a relative face value calculation

100% will vest if underpin met

However, as the exercise price is set at a premium to the share price at grant, participants will only be able to realise value if the share price exceeds 80p.

 

Options under the IRP will only have value if the share price exceeds the option price and vesting requires that the Company has delivered market competitive total returns to shareholders. The exercise price has been set at 80p (a premium of 29% to the share price of 62p at grant date).

The performance conditions are also subject to the discretion of the Remuneration Committee to adjust or over-ride the formulaic outcome and determine the number of Shares in respect of which the Option will vest, taking into account such factors it may in its discretion determine, potentially including the underlying performance of the Group and the Participant's individual performance.

 

The normal vesting date for each of the Options is 12 October 2026. To the extent that an Option vests, it is subject to a further holding period of two years, during which time it will not be capable of exercise. This means that, in line with the UK Corporate Governance Code, each Option will be subject to an aggregate vesting and holding period of five years and no value can be realized by the option holder until 12 October 2028 at the earliest.

 

The number of Shares shown in the first table above represents the maximum that may be acquired if all performance conditions are achieved in full. The Company may also transfer additional Shares to reflect the value of dividends that would have been paid on the Shares in respect of which the Option vests over the period between the Award Date and the end of the post-vesting holding period.

The relevant information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation as retained in UK law.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Clive Vacher

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

Grant of options under the rules of the De La Rue Performance Share Plan 2020 (PSP) and the De La Rue Investor Returns Plan (IRP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.00

 

PSP: 309,602

IRP: 640,878

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

12 October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ruth Euling

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/MD, Currency

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

Grant of options under the rules of the De La Rue Performance Share Plan 2020 (PSP) and the De La Rue Investor Returns Plan (IRP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.00

 

PSP: 102,454

IRP: 212,079

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

12 October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

Jon Messent, Company Secretary

Contact Number: 01256 605212

13 October 2023

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANEDFASDFEA
Date   Source Headline
1st Mar 20105:59 pmRNSTotal Voting Rights
18th Feb 20108:35 amRNSAdditional Listing
1st Feb 20103:03 pmRNSTotal Voting Rights
26th Jan 20107:00 amRNSInterim Management Statement
13th Jan 20102:40 pmRNSDirector/PDMR Shareholding
31st Dec 20091:01 pmRNSTotal Voting Rights
31st Dec 20091:00 pmRNSTotal Voting Rights
24th Dec 200911:01 amRNSDirector/PDMR Shareholding
14th Dec 20091:16 pmRNSAdditional Listing
3rd Dec 20094:27 pmRNSHolding(s) in Company
30th Nov 20093:03 pmRNSTotal Voting Rights
24th Nov 20097:00 amRNSInterim Statement Six Months To 26 September 2009
18th Nov 20091:03 pmRNSResolution of SFO Investigation
16th Nov 20094:46 pmRNSBlocklisting Interim Review
2nd Nov 200910:23 amRNSTotal Voting Rights
6th Oct 20098:23 amRNSHolding(s) in Company
1st Oct 200910:13 amRNSTotal Voting Rights
16th Sep 200910:29 amRNSHolding(s) in Company
16th Sep 20097:00 amRNSPreClose Statement-Six Months to 26 September 2009
2nd Sep 20097:00 amRNSDirectorate Change
1st Sep 20094:51 pmRNSTotal Voting Rights
3rd Aug 20094:06 pmRNSHolding(s) in Company
31st Jul 20093:27 pmRNSTotal Voting Rights
31st Jul 20093:01 pmRNSDirector/PDMR Shareholding
28th Jul 20092:41 pmRNSHolding(s) in Company
23rd Jul 20094:35 pmRNSResult of AGM
23rd Jul 20097:00 amRNSAGM Chairman's Statement and IMS.
10th Jul 20093:54 pmRNSAnnual Information Update
1st Jul 20093:49 pmRNSTotal Voting Rights
29th Jun 20098:27 amRNSAdditional Listing
24th Jun 20094:01 pmRNSDirector/PDMR Shareholding
16th Jun 20095:44 pmRNSAnnual Financial Report
11th Jun 20093:36 pmRNSDirectorate Change
11th Jun 20093:24 pmRNSDe La Rue Wins Biometric Passport Contract
8th Jun 200910:59 amRNSHolding(s) in Company
5th Jun 20093:53 pmRNSDirector/PDMR Shareholding
1st Jun 20094:21 pmRNSDirector/PDMR Shareholding
1st Jun 20093:21 pmRNSTotal Voting Rights
29th May 20091:18 pmRNSHolding(s) in Company
27th May 20096:14 pmRNSHolding(s) in Company
27th May 200912:17 pmRNSAdditional Listing
21st May 20094:58 pmRNSHolding(s) in Company
20th May 20097:00 amRNSPreliminary Statement to 28 March 2009
13th May 20091:43 pmRNSBlocklisting Interim Review
1st May 20091:20 pmRNSTotal Voting Rights
28th Apr 20095:25 pmRNSHolding(s) in Company
24th Apr 20099:51 amRNSAdditional Listing
22nd Apr 20094:39 pmRNSHolding(s) in Company
22nd Apr 20094:39 pmRNSHolding(s) in Company
20th Apr 20097:00 amRNSRe Camelot Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.